More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
AUM
$72278469
P/E ratio
21.7
Dividend yield
0.6042%
Expense ratio
0.95%
Beta
1.246725
Previous close
$79.36
Today's open
$79.94
Day's range
$79.94 - $83.50
52 week range
$44.20 - $90.91
show more
Headquarters
US
Exchange
NASDAQ Global Market
Issue type
Exchange-Traded Fund
Alternatives
Trading Tools
Medical Technology Stocks: Innovation Endures As Valuations Reset
Investors are questioning the staying power of medical technology (medtech) stocks, which have fallen from grace since the COVID-19 pandemic. The starting point is to distinguish between medtech and other healthcare industries.
Seeking Alpha • May 2, 2026

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War
Survey data underscored how the war in the Middle East has already had a material impact on economic growth around the world. Drilling down deeper, the data showed weaker growth trends were recorded across all major industries globally.
Seeking Alpha • Apr 12, 2026

Investing In Health Stocks - How Policy Clarity Is Opening Doors
The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.
Seeking Alpha • Nov 11, 2025

BIB: A Tactical 2 X Leveraged Biotech ETF
BIB seeks 2× the daily return of the Nasdaq Biotechnology Index, amplifying both gains and losses through leverage. A higher expense ratio reflects leverage costs and management fees; 24 bps difference largely from borrowing and rebate adjustments. Designed for tactical investors, contrasting with MPT's long-term strategic approach assuming market efficiency.
Seeking Alpha • Oct 23, 2025

Pharma Tariffs Back In Spotlight On New Trump Threat
President Donald Trump delivered the pharmaceutical industry another blow this week, threatening 100% tariffs on some companies.
Investors Business Daily • Sep 26, 2025

Donald Trump Is Finally Making Good On Pharma Tariffs Threats, But Stocks Yawn
Trump said late Tuesday his administration will begin implementing pharmaceutical tariffs next month, making good on months of threats.
Investors Business Daily • Jul 16, 2025

Trump Threatens To Slam Pharmaceuticals With Up To 200% Tariffs
President Donald Trump threatened Tuesday to levy up to 200% tariffs on drugs imported into the U.S. "very soon."
Investors Business Daily • Jul 8, 2025

Healthcare Sector Checkup As U.S. Looks To Change Regulations
Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.
Seeking Alpha • May 30, 2025

Seeking Stocks With Vitality In The Volatile Healthcare Sector
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?
Seeking Alpha • Feb 25, 2025

Will The Next Batch Of Tech Earnings Encourage Investors To Rotate Back In?
All eyes will remain on big tech this week with Microsoft, Amazon, Meta, and Apple set to report for Q2. Outlier earnings this week include - McDonald's & Boeing. During this second peak week of the Q2 season, nearly 2,500 companies are set to report.
Seeking Alpha • Jul 30, 2024

¹ Disclosures

Open an M1 investment account to buy and sell ProShares Ultra NASDAQ Biotechnology commission-free¹. Build wealth for the long term using automated trading and transfers.